Showing results (2291-2300 of 5,003) with videos related to

Sort By:
Pageof 501
The Cochrane Database of Systematic Reviews|December 2, 2015
Interventions for the treatment of oral and oropharyngeal cancers: targeted therapy and immunotherapyKelvin K W Chan, Anne-Marie Glenny, Jo C Weldon, et al.
Lupus|April 17, 2008
Rapamycin prevents the development of nephritis in lupus-prone NZB/W F1 miceS L Lui, S Yung, R Tsang, et al.
The Science of the Total Environment|December 13, 2016
An analysis of aerosol liquid water content and related impact factors in Pearl River DeltaHaobo Tan, Mingfu Cai, Qi Fan, et al.
The Journal of Nervous and Mental Disease|March 21, 2014
Prevalence and determinants of depression among survivors 8 months after the Wenchuan earthquakeZhiyong Qu, Chong-Wen Wang, Xiulan Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancerEddy S Leman, Robert E Schoen, Ahmed Magheli, et al.
Journal of Clinical Microbiology|January 31, 2014
Clinical and virologic factors associated with reduced sensitivity of rapid influenza diagnostic tests in hospitalized elderly patients and young childrenMartin C W Chan, Nelson Lee, Karry L K Ngai, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 16, 2017
Quantifying Health Utilities in Patients Undergoing Stereotactic Body Radiation Treatment for Liver Metastases for Use in Future Economic EvaluationsB Warren, P Munoz-Schuffenegger, K K W Chan, et al.
Oral Oncology|January 23, 2017
Definitive proton beam therapy for adenoid cystic carcinoma of the nasopharynx involving the base of skullMichelle S Gentile, Darwin Yip, Norbert J Liebsch, et al.
Oncogene|March 21, 2017
The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP-PKA-EGFR-STAT3 axisM Zhou, M T Mok, H Sun, et al.
Cancer Epidemiology|June 21, 2014
Longer duration of combination antiretroviral therapy reduces the risk of Hodgkin lymphoma: A cohort study of HIV-infected male veteransM A Kowalkowski, M A Mims, R S Day, et al.
Pageof 501